http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0328125-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
filingDate 1989-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1990-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0328125-A3
titleOfInvention Process for the enzymatic separation of the optical isomers of racemic alpha-alkyl-substituted primary alcohols
abstract A process is disclosed for the biotechnological resolution by means nof enzymatic transesterification of the relevant racemic mixture of the noptical isomers of α-alkyl-substituted alcohols having the formula (I): n nwherein: nR represents a linear or branched (C₁-C₂₀)-alkyl or alkenyl group or an naryl group, also substituted or condensed with other groups, in parti­ncular a group of formula (II) or (III): n nwherein: nR ii represents a (C₁-C₈)-alkyl group, a (C₁-C₄)-alkenyl group, an alkoxy, nphenyl, phenoxy, benzoyl, heterocyclic group; nR iii represents a hydrogen or halogen atom; nR iv represents a (C₁-C₄)-alkyl group, nand wherein nR i represents a (C₁-C₄)-alkyl group either equal to, or different nfrom, R, nin the presence of an enzyme either free or immobilized on a nsupport capable of selectively causing the S isomer to be nesterified, with the R isomer being left substantially nunchanged, and said isomers are then separated according to ntechniques known from the prior art. n The process is used in the synthesis of anti-­ninflammatory agents.
priorityDate 1988-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0231089-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0274277-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240

Total number of triples: 18.